AmyriAD
2 known investors
Find your way into AmyriAD
88 people in our graph share verified history with the AmyriAD team — schools, employers, funds. One of them is your warm intro.
Chen Yang Siaunlockedknows Anil K. Ratty · together at Raffles Institution
×11knows the team · via Raffles Institution
Amyriad Therapeutics develops disease-modifying therapies for Alzheimer's disease, with a lead candidate called Ismidenon that employs novel cholinergic enhancement mechanisms. The company is led by neuroscientists and clinical experts focused on restoring cognitive function in aging-related neurodegeneration.
Founders & leadership
AK
Anil K. RattyinCEO & FounderAnil K. Ratty is a biochemist and molecular biologist who has held research positions at institutions including Buffalo General Hospital, Roswell Park Cancer Institute, and the Institute of Molecular and Cell Biology in Singapore. He previously served as Regional Director for Asia at a US biotech company and has founded or co-founded multiple biotech and IT ventures before launching Amyriad Therapeutics, which develops cognitive restoration therapies for Alzheimer's disease.
Investors · 2
In the news
Frequently asked questions
- What does AmyriAD do?
- Amyriad Therapeutics develops disease-modifying therapies for Alzheimer's disease, with a lead candidate called Ismidenon that employs novel cholinergic enhancement mechanisms. The company is led by neuroscientists and clinical experts focused on restoring cognitive function in aging-related neurodegeneration.
- Who founded AmyriAD?
- AmyriAD was founded by Anil K. Ratty.
- Who are AmyriAD's investors?
- AmyriAD's investors include Elevat3 Capital, What If Ventures.